Pharmacy Disclosure Log 2022

1. Asthma Treatment Response 7819
2. Biologic and Biosimilar Products within Rheumatology Response 7421
3. Biologic Medications within Dermatology Response 7390
4. Breast Cancer Response 7291
5. Breast Cancer Patients Response 7534
6. Breast Cancer Response 7723
7. Breast Cancer Response 7759
8. Colorectal Cancer Response 7565
9. CQUIN Response 7375
10. CQUIN Data Response 7511
11. Dermatology Drugs Response 7432
12. Dermatology Patients Response 7388
13. Dermatological Conditions Response 7809
14. Diffuse Large B Cell Lymphoma Response 7544
15. Fungal Infections Response 7823
16. Fungal Infections Response 7823 - Attachment
17. Gastric and Gastro-Oesophageal Junction Cancer Response 7335
18. Gastric and Gastro-Oesophageal Response 7554
19. Haematology Response 7810
20. Hartmann IV solution Response 7405
21. Hepatocellular Carcinoma Response 7325
22. Hidradenitis Suppurativa Response 7666
23. Immunoglobulin Treatments Response 7326
24. Immune Thrombocytopenia Response 7368
25. Immune Thrombocytopenia Response 7368 - Attachment
26. Jakavi Response 7370
27. Local Treatment Guidelines Non-Small Cell Lung Cancer Response 7830
28. Lung Cancer Treatment Response 7373
29. Lung Cancer Patients Response 7713
30. Melanoma Response 7371
31. Multiple Myeloma Response 7318
32. New Biologic Medications within Dermatology Response 7600
33. New Biologic Medications within Dermatology Response 7818
34. Nivolumab Response 7833
35. Non-Small Cell Lung Cancer (NSCLC) Response 7479
36. Non-Small Cell lung Cancer (NSCLC) Response 7286
37. Oesophageal and Gastric Cancer Response 7778
38. Patients Receiving Treatment Response 7536
39. Patients Treated for Renal Cell Carcinoma Response 7491
40. Patients Treated for Cervical Cancer Response 7648
41. Patients treated with a combination of Dabrafenib and Trametinib Response 7512
42. Patients treated with Anidulafungin Response 7505
43. Patients Treated with Revolade, Nplate, Doptelet, Tavlesse Response 7616
44. Patients Treated with Revolade, Nplate, Doptelet, Tavlesse Response 7616 - Attachment
45. Patient Treatment Response 7746
46. Prostate Cancer Response 7738
47. Prostate Cancer Response 7331
48. Renal Cell Carcinoma Response 7729
49. Rheumatoid Arthritis Response 7523
50. Rheumatoid Arthritis Response 7523 - Attachment
51. Rheumatology Treatment Response 7269
52. Rheumatology Response 7647
53. Treatment of HR+ Adjuvant Breast Cancer Response 7796
54. Treatment for Lung Cancer Response 7623
55. Systemic Anti-Cancer Therapies Response 7499
56. The Treatment of Melanoma Response 7577
57. Triple Negative Breast Response 7315
58. Urothelial Cancer Patients Response 7324
59. Urothelial Cancer Patients Response 7538
60. Urothelial Cancer Response 7770
61. Usage of Somatropins Response 7458

• Share:
• Facebook
• Twitter
• LinkedIn